Adaptimmune - ADR (ADAP) Stock Price Today, Chart, Quote and News | baraka

A

Adaptimmune - ADR (ADAP)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Adaptimmune - ADR (ADAP)

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. Its SPEAR T-cell platform enables it... Read more

Open
USD0.88
High
USD0.88
Low
USD0.84
52 Week High
USD2.05
Monthly Return
-17.00%
Revenue
112M

Daily Vol.
868.20k
Avg. Daily Vol.
1.12M
Market Cap.
223M
52 Week Low
0.42
Annual Return
31.00%

Stock News

Google gets new head of search and ad business as part of AI-focused reshuffling

Google gets new head of search and ad business as part of AI-focused reshuffling

MarketWatch

Jim Cramer On Oracle Corporation (ORCL): ‘I Like The Prospects’

Jim Cramer On Oracle Corporation (ORCL): ‘I Like The Prospects’

Yahoo

Warren Buffett's Strategic Reduction in Bank of America Holdings

Warren Buffett's Strategic Reduction in Bank of America Holdings

Yahoo

Flowserve: More Room To Run Despite The Stock's Recent Rally

Flowserve: More Room To Run Despite The Stock's Recent Rally

SeekingAlpha

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.